BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 11204575)

  • 1. Von Willebrand factor does not vary during normal menstrual cycle.
    Onundarson PT; Gudmundsdottir BR; Arnfinnsdottir AV; Kjeld M; Olafsson O
    Thromb Haemost; 2001 Jan; 85(1):183-4. PubMed ID: 11204575
    [No Abstract]   [Full Text] [Related]  

  • 2. Standardisation of factor VIII--V. Calibration of the 2nd International Standard for Factor VIII and von Willebrand factor activities in plasma.
    Heath AB; Barrowcliffe TW
    Thromb Haemost; 1992 Aug; 68(2):155-9. PubMed ID: 1412160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in von Willebrand factor and factor VIII levels during the menstrual cycle.
    Miller CH; Dilley AB; Drews C; Richardson L; Evatt B
    Thromb Haemost; 2002 Jun; 87(6):1082-3. PubMed ID: 12083494
    [No Abstract]   [Full Text] [Related]  

  • 4. Standardisation of factor VIII and von Willebrand factor in plasma: calibration of the 4th International Standard (97/586).
    Hubbard AR; Rigsby P; Barrowcliffe TW
    Thromb Haemost; 2001 Apr; 85(4):634-8. PubMed ID: 11341497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification and facilitated comparison of von Willebrand factor multimer patterns by densitometry.
    Studt JD; Budde U; Schneppenheim R; Eisert R; von Depka Prondzinski M; Ganser A; Barthels M
    Am J Clin Pathol; 2001 Oct; 116(4):567-74. PubMed ID: 11601142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Standardization of von Willebrand factor propeptide: value assignment to the WHO 6th IS Factor VIII/von Willebrand factor, plasma (07/316).
    Hubbard AR; Hamill M; Eikenboom HC; Montgomery RR; Mertens K; Haberichter S;
    J Thromb Haemost; 2012 May; 10(5):959-60. PubMed ID: 22696769
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparative multi-laboratory assessment of three factor VIII/von Willebrand factor concentrates.
    Favaloro EJ; Bukuya M; Martinelli T; Tzouroutis J; Duncan E; Welldon K; Collecutt M; Aumann H; Thom J; Gilmore G
    Thromb Haemost; 2002 Mar; 87(3):466-76. PubMed ID: 11916080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of six commercial plasma references for factor VIII, factor IX and von Willebrand factor. On behalf of the Subcommittee for Factor VIII and IX of the Scientific and Standardization Committee of the ISTH.
    Kasper CK; Aronson DL; Davignon G; Foster P; Hillman-Wiseman C; Lusher JM; Manco-Johnson M; Meade JB; Montgomery RR; Rickles FR
    Thromb Haemost; 1995 Sep; 74(3):987-9. PubMed ID: 8571334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. von Willebrand factor/factor VIII binding is not affected by the Arg89Gln polymorphism in von Willebrand factor.
    Nesbitt IM; Goodeve AC; Preston FE; Peake IR
    Thromb Haemost; 1996 Nov; 76(5):820-1. PubMed ID: 8950801
    [No Abstract]   [Full Text] [Related]  

  • 10. Factor VIII and von Willebrand factor changes during normal pregnancy and puerperium.
    Sánchez-Luceros A; Meschengieser SS; Marchese C; Votta R; Casais P; Woods AI; Nadal MV; Salviú MJ; Lazzari MA
    Blood Coagul Fibrinolysis; 2003 Oct; 14(7):647-51. PubMed ID: 14517489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The factor VIII/von Willebrand factor ratio discriminates between reduced synthesis and increased clearance of von Willebrand factor.
    Eikenboom JC; Castaman G; Kamphuisen PW; Rosendaal FR; Bertina RM
    Thromb Haemost; 2002 Feb; 87(2):252-7. PubMed ID: 11859851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative in vitro evaluation of six von Willebrand factor concentrates.
    Lethagen S; Carlson M; Hillarp A
    Haemophilia; 2004 May; 10(3):243-9. PubMed ID: 15086321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of von Willebrand disease type 2N (Normandy) in Australia: a cross-laboratory investigation using different methods.
    Rodgers SE; Lerda NV; Favaloro EJ; Duncan EM; Casey GJ; Quinn DM; Hertzberg M; Lloyd JV
    Am J Clin Pathol; 2002 Aug; 118(2):269-76. PubMed ID: 12162689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variations in coagulation factors in women: effects of age, ethnicity, menstrual cycle and combined oral contraceptive.
    Kadir RA; Economides DL; Sabin CA; Owens D; Lee CA
    Thromb Haemost; 1999 Nov; 82(5):1456-61. PubMed ID: 10595638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cold storage of citrated whole blood induces drastic time-dependent losses in factor VIII and von Willebrand factor: potential for misdiagnosis of haemophilia and von Willebrand disease.
    Böhm M; Täschner S; Kretzschmar E; Gerlach R; Favaloro EJ; Scharrer I
    Blood Coagul Fibrinolysis; 2006 Jan; 17(1):39-45. PubMed ID: 16607078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor VIII-von Willebrand factor binding defects in autosomal recessive von Willebrand disease type Normandy and in mild hemophilia A. New insights into factor VIII-von Willebrand factor interactions.
    Jacquemin M
    Acta Haematol; 2009; 121(2-3):102-5. PubMed ID: 19506355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis and classification of von Willebrand factor/factor VIII concentrates: impact on treatment of patients with von Willebrand disease.
    Budde U; Metzner HJ; Müller HG
    Semin Thromb Hemost; 2006 Sep; 32(6):626-35. PubMed ID: 16977573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that NH2-terminal but not COOH-terminal moiety of plasma von Willebrand factor binds to factor VIII.
    Jorieux S; Magallon T; Mazurier C
    Thromb Res; 1987 Oct; 48(2):205-10. PubMed ID: 3122360
    [No Abstract]   [Full Text] [Related]  

  • 19. Laboratory diagnosis of von Willebrand disorder. Current practice in the southern hemisphere.
    Favaloro EJ; Bonar R; Sioufi J; Hertzberg M; Street A; Lloyd J; Marsden K;
    Am J Clin Pathol; 2003 Jun; 119(6):882-93. PubMed ID: 12817437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cold-dependent loss of factor VIII von Willebrand factor activities in citrated whole blood is reversed by rewarming.
    Refaai MA; Lukoszyk M; Hughes J; Eby CS; Van Cott EM
    Am J Clin Pathol; 2005 Dec; 124(6):972; author reply 973. PubMed ID: 16416745
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.